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Introduction
Autophagy is an intracellular pathway for bulk protein degrada-
tion and damaged organelles removal by lysosomes.1 Autophagy 
is initiated by the formation of a cup-shaped membrane, called 
phagophore.2 Next, the phagophore enwraps parts of the cyto-
plasm to form a double-membrane vesicle, the autophagosome, 
which eventually fuses with lysosomes.1,3 Two evolutionarily 
conserved ubiquitin-like protein conjugation systems are nec-
essary for the formation of the autophagosome, the ATG12-
ATG5 and the ATG8-phosphatidylethanolamine (PE).4 Among 
them, while ATG8 in yeast is represented by a single gene, its 
homologs in humans are represented by at least eight members 
that can be divided into two subgroups based on their amino 
acid sequence homology: the microtubule-associated protein 1 
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light chain 3 (LC3) family (LC3A, LC3B, LC3B2 and LC3C) 
and the GABA(A) receptor-associated protein (GABARAP) 
family (GABARAP, GABARAPL1, GABARAPL2 and 
GABARAPL3).5 Importantly, apart from GABARAPL3,6-8 
they are all conjugated to PE and, consequently, incorporated 
into autophagosomal membranes. The two protein subfamilies 
are essential for autophagosomes biogenesis and probably have 
distinct roles in the overall autophagic process.8,9 Notably, the 
functions of ATG8 human orthologs are mostly based on their 
interaction with a large cohort of proteins, with extensive binding 
partner overlap between family members.10,11
Autophagy is one of the major responses to stress in eukary-
otic cells and is implicated in several pathological conditions such 
as infections, neurodegenerative diseases and cancer.12-14 Still, as 
upstream signaling events leading to stimulation of autophagy 
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which we confirmed to be devoid of self-activation (Fig. 1A, and 
data not shown), suggesting that MAPK15 was able to interact 
with these proteins. Also, as they both share high identity and 
belong to the same protein family of LC3B,29,30 this observation 
suggested the possibility that MAPK15 also interacts with this 
protein. Therefore, we performed in vitro affinity precipitation 
experiments using full-length, HA-tagged, MAPK15 expressed 
in 293T cells and bacterially expressed, GST-tagged GABARAP, 
GABARAPL1 and LC3B. As shown in Figure 1B, all GST-tagged 
ATG8-like proteins, but not GST alone, were able to interact in 
vitro with MAPK15, albeit with different affinities. To determine 
whether MAPK15 was able to interact also in vivo with ATG8-
like proteins, we performed affinity-precipitation experiments in 
HeLa cells, co-transfecting 6xHis-tagged MAPK15 with EGFP-
tagged, LC3B, GABARAP, and GABARAPL1. As shown, they 
all coprecipitated in vivo with MAPK15 (Fig. 1C), although with 
different relative affinities, confirming results previously obtained 
in vitro. Ultimately, we demonstrated that endogenous MAPK15 
was also able to interact, in vivo, with endogenous LC3B 
(Fig. 1D), altogether showing that MAPK15 indeed interacts 
with mammalian ATG8-like proteins.
MAPK15 localized to autophagic structures. Each member 
of the LC3/GABARAP family of proteins consists of two forms 
with different subcellular localizations.5 Among them, form I 
(e.g., LC3B-I) is localized to the cytoplasm while form II (e.g., 
LC3B-II), upon addition of a lipidic moiety, is relocalized onto 
autophagosomal membranes.8,29,31 Hence, we hypothesized that 
MAPK15 might be recruited to autophagosomal vesicles by inter-
acting with ATG8-like proteins. Still, as no information is cur-
rently available regarding MAPK15 localization to intracellular 
membranes, we first decided to characterize MAPK15 subcellular 
distribution by confocal microscopy. Immunofluorescence analy-
sis of HeLa cells, transiently expressing MAPK15, revealed that 
this MAP kinase, besides localizing to the cytoplasm and the 
nucleus,25 also exhibited a puncta pattern (Fig. 2A), suggesting 
that MAPK15 could have a vesicular membrane localization. To 
confirm this observation, we also performed cell fractionation 
experiments. As shown in Figure 2B, MAPK15 was localized to 
both cytoplasmatic and nuclear fractions, as previously demon-
strated.25 Though, the membrane compartment also showed con-
siderable amounts of the MAPK15 protein (Fig. 2B).
Next, we tested the hypothesis that this MAP kinase was 
also localized to autophagic vesicles. To this aim, we performed 
immunofluorescence colocalization analysis between MAPK15 
and endogenous autophagic vesicle markers, upon permeabiliza-
tion of cells with digitonin in order to eliminate the background 
signal due to their cytoplasmatic forms.32 Consistently with its 
interaction with ATG8-like proteins, MAPK15, indeed, partially 
colocalized with endogenous LC3B, GABARAP and SQSTM1/
p62 (Fig. 2C and D), all classical markers for membranes of 
autophagosomal origin. However, MAPK15 showed a more lim-
ited colocalization rate with LAMP1 (Fig. 2C and D), an estab-
lished marker for lysosomal and autophagolysosomal vesicles.33 
Finally, we also performed triple localization experiments, con-
firming that this MAP kinase resided on cytoplasmic vesicles of 
clear autophagosomal origin, being positive for both LC3B and 
are still poorly characterized, possibilities to interfere with this 
process and, eventually, take advantage of its modulation for 
therapeutic purposes are limited. In this context, mitogen-acti-
vated protein (MAP) kinases are a family of proline-directed ser-
ine/threonine kinases coordinating the signaling from a variety 
of extracellular and intracellular stimuli to regulate gene expres-
sion, cell metabolism, and cytoskeleton dynamics.15 Importantly, 
the MAPK1/ERK2, MAPK8/JNK and MAPK14/p38α mem-
bers of this family have been already involved in the control of 
the autophagic process.16,17 Mitogen-activated protein kinase 15 
(MAPK15/ERK8; ERK7) is the last identified member of the 
MAP kinase family.18 Although possessing a typical Thr-X-Tyr 
activation motif (TEY), there is no evidence that MAPK15 is 
placed in a “classical,” three-tiered, MEKK-MEK-MAPK cas-
cade as the other MAP kinases. Conversely, phosphorylation of 
TEY motif seems to be catalyzed by MAPK15 itself, therefore 
suggesting that autophosphorylation has a key role in controlling 
MAPK15 activity and functions.19 Still, MAPK15 activity can 
be further modulated by serum, endogenous phosphatases, DNA 
damage and human oncogenes.18,20,21 In line with the role of all 
the MAP kinases in controlling gene expression,22 MAPK15 has 
been also reported to stimulate the activity of the JUN proto-
oncogene,23 and to reduce the activity of nuclear receptors such 
as androgen receptor, glucocorticoid receptors and estrogen-
related receptor α (ESRRA/ERRα).24-26 Interestingly, recent data 
suggest a role for MAPK15 in cell transformation23 and in the 
protection of genomic integrity, by inhibiting proliferating cell 
nuclear antigen (PCNA) degradation.27 Ultimately, MAPK15 
inhibition strongly affects telomerase activity,28 suggesting this 
kinase as an important player in the mechanisms contributing to 
bypass replicative senescence and to immortalize cells.
To better understand the function of MAPK15, we used a 
yeast two-hybrid assay to screen a mouse cDNA library for poten-
tial interacting proteins.25 Through this approach, we identified 
different members of the mammalian ATG8 family of proteins 
as binding partners for the C-terminal domain of MAPK15, rais-
ing the possibility that this MAP kinase may be involved in the 
control of autophagy. Here, we provide evidence that, indeed, 
MAPK15 is localized to autophagic structures and controls, in 
a kinase-dependent fashion, both basal and starvation-induced 
autophagy. Since MAPK15 is activated by different stimuli that 
induce autophagy,19,20 this kinase could therefore provide an 
unexpected link to connect nutrient- and stress-dependent signal-
ing pathways to the activation of this important cellular process.
Results
MAPK15 interacted with mammalian ATG8-like proteins. In 
order to identify novel MAPK15 interacting proteins, we per-
formed a yeast two-hybrid screening.25 As MAPK15 has a unique 
C-terminal portion, which distinguishes this MAP kinase from 
other members of the family, we decided to use this domain as 
bait for the screening. Based on the evidence that MAPK15 is 
highly expressed in the nervous system,18 we chose to screen a 
mouse brain library of cDNAs. Among the positive clones, we 
found multiple cDNAs encoding for Gabarap and Gabarapl1, 
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by using anti-ATG8 proteins antibodies specifically recognizing 
their lipidated form II. Indeed, using a well-established stimulus 
promoting autophagy, the MTOR inhibitor rapamycin,35 form 
II protein levels increased in our cellular system, reaching a sig-
nificant enhancement at around 2 h for LC3B-II and 4 h for 
GABARAP-II (Fig. S1, left panels; refs. 36–38). As MAPK15 
activity is controlled by autophosphorylation,19,39 we overex-
pressed it to stimulate its function (Fig. S2; refs. 21 and 24). 
As shown in Figure 3A, MAPK15 induced LC3B-II at levels 
comparable to rapamycin and starvation, suggesting its ability 
SQSTM1 (Fig. 2E). Altogether, our data therefore demonstrated 
that MAPK15 localizes on autophagic structures and suggested 
that such localization may be important for this kinase to have 
full access to pools of specific substrates such as other ATG pro-
teins, to control the autophagic pathway.
MAPK15 induced autophagy. Based on these data, we next 
decided to investigate the role of MAPK15 in controlling auto-
phagy. As previously described,7,34 induction of autophagy is 
associated to an increase of the form II of LC3B (and of its related 
proteins GABARAP and GABARAPL1) that can be monitored 
Figure 1. MAPK15 interacted, in vitro and in vivo, with GABARAP, GABARAPL1 and LC3B. (A) Two positive clones, identi!ed by two-hybrid screening, 
encoding GABARAP and GABARAPL1 were tested to be devoid of autoactivation. Yeast cells were cotransformed with the pACT2 vector containing 
the Gabarap (upper row) and Gabarapl1 (lower row) cDNA, respectively, with pGBKT7 alone (left) or with pGBKT7-MAPK15_C-term (right), and streaked 
on selective medium. (B) Bacterially expressed GST-GABARAP (lanes 3–4), GST-GABARAPL1 (lanes 5–6) and GST-LC3B (lanes 7–8) or GST alone (lanes 
1–2), immobilized on glutathione-Sepharose Beads 4B, were incubated, for a"nity precipitation (AP), with total lysates (TL) of 293T cells transiently 
transfected with a control vector or with HA-MAPK15, then analyzed by western blot (WB). (C) HeLa cells were cotransfected with a control vector or 
with GFP-LC3B, GFP-GABARAPL1, GFP-GABARAP in presence or absence of MAPK15–6XHis. Lysates (1 mg) were incubated with NiNTA-Sepharose Beads 
4B, subjected to in vivo a"nity precipitation, and then analyzed by WB. The total and MAPK15-bound amounts of GFP-tagged ATG8-like protein were 
quanti!ed by NIH ImageJ software. (D) HeLa cells lysates (5 mg) were immunoprecipitated with control IgG or anti-MAPK15 antibody and analyzed by 
WB. LC3B was detected with anti-LC3B antibody (Sigma Aldrich).
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assay to monitor autophagy and to understand its dynamics.5 In 
order to confirm our previous results and to expand their biologi-
cal significance, we next performed indirect immunofluorescence 
analysis in our inducible cell system, aimed at scoring an increase 
in puncta for endogenous LC3B. As shown in Figure 3D, stimu-
lation of MAPK15 expression in inducible HeLa cells led to a 
~6.8-fold increase in the number of autophagic structures, as com-
pared with uninduced cells (quantification performed through 
unbiased analysis using the Quantitation Module of Volocity 
software). To better appreciate autophagosomal formation, we 
also used bafilomycin A1, an inhibitor of lysosomal acidification, 
to prevent lysosomal degradation of autophagosome-associated 
LC3B.42 Bafilomycin A1 allows, in fact, the detection of each 
autophagosome formed in the time-lapse between addition of 
the drug to cells and harvesting. As shown in Figure 3E, despite 
the higher background due to the enhancing effect of the inhibi-
tor on the number of autophagic vesicles, MAPK15 expression 
in bafilomycin A1-treated, HeLa inducible cells also enhanced 
the amount of autophagic structures (~2.3-fold increase) in com-
parison to uninduced cells. As a control, MAPK15 protein levels 
were only slightly affected by this blocker of lysosomal degra-
dation (Fig. S7), supporting the already established preeminent 
role of the ubiquitin-proteasome pathway in the turnover of the 
MAPK15 protein.43,44
Similarly to LC3B, also GABARAP and GABARAPL1 are 
lipidated by the autophagic enzymatic machinery and associated 
to affect autophagy, as also confirmed by interfering with ATG7 
(Fig. S3) and ATG5 (Fig. S4) expression in HeLa cells expressing 
this MAP kinase. Still, the assay scoring an increase of LC3B-II 
cannot discriminate between an induction of autophagy or an 
inhibition in late stage of this cellular process.5,40 To distinguish 
between these two situations, we therefore used inhibitors of 
lysosomal acid proteases, according to autophagy methods guide-
lines.5 In cells overexpressing MAPK15, treatment with prote-
ase inhibitors, namely E64d (Fig. 3B) and leupeptin (Fig. S5), 
further increased LC3B-II level when compared with MAPK15 
overexpression alone. This result indicated that the LC3B-II 
accumulation, obtained in presence of activated MAPK15, was 
due to autophagy stimulation and not to an impaired clearance.
In order to circumvent potential biases arising from stress 
induced by transient transfection of the MAPK15 cDNA,41 we 
next decided to analyze the ability of this kinase to stimulate 
autophagy by using a MAPK15-inducible cell line, HeLa T-Rex 
MAPK15. In this cellular system, the expression of MAPK15, 
induced by doxycycline (Fig. 3C; Fig. S6A), also led to the 
increase of LC3B-II (Fig. 3C). Interestingly, the expression in 
the same inducible system of an exogenous protein, the prod-
uct of the LacZ gene, did not manifest any effect on LC3B-II 
(Fig. S6B), indicating the absence of nonspecific effects due to 
doxycycline or protein overexpression.
Indirect immunofluorescence microscopy, scoring the forma-
tion of punctate intracellular vacuoles stained for LC3B, is a key 
Figure 2 (See previous page). MAPK15 localized to autophagic structures. (A) HeLa cells were transfected with HA-MAPK15 cDNA. Cells were permea-
bilized with 0.2% Triton X-100. HA-MAPK15 proteins were immuno-labeled with anti-MAPK15 antibody and revealed with AlexaFluor488-conjugated 
secondary antibody. Nuclei were stained with DAPI. (B) HeLa cells stably expressing HA-MAPK15 were subjected to fractionation using the Subcellular 
Protein Fractionation Kit (Thermo Scienti!c). Lysates were subjected to SDS-PAGE followed by WB with anti-MAPK15 (top), anti-NFKBIA (middle top), 
anti-Calnexin (middle bottom), and anti-JUN (bottom) antibodies. C, cytoplasmic fraction; M, membrane fraction; N, nuclear fraction. (C) A clone of 
HeLa cells stably expressing HA-MAPK15 were permeabilized with 100 μg/ml digitonin. Cells were stained with appropriate antibodies (anti-MAPK15, 
anti-LC3B MBL, anti-GABARAP, anti-SQSTM1 and anti-LAMP1) and revealed with AlexaFluor488- and AlexaFluor555-conjugated secondary antibodies. 
Nuclei were stained with DAPI. The region enclosed in the white square has been enlarged in the smaller panel for better appreciation of the colocal-
izations. Arrows indicate colocalization areas. Similar results were obtained in at least 3 independent clones. (D) Colocalization rate of MAPK15 and 
LC3, GABARAP, SQSTM1 and LAMP1 respectively was obtained by analyzing at least 400 cells/sample from three di#erent experiments (n = 3).  
(E) HeLa cells stably expressing HA-MAPK15 were transfected with pCEFL-GFP-LC3B. Twenty-four hours later, cells were permeabilized with 100 μg/ml 
digitonin. Cells were stained with anti-SQSTM1 and anti-MAPK15 antibodies and revealed with AlexaFluor555- and AlexaFluor647-conjugated second-
ary antibodies. Nuclei were stained with DAPI. The region enclosed in the white square has been enlarged in the lower panels for better appreciation 
of the colocalizations. Arrows indicate colocalization areas.
Figure 3 (See opposite page). MAPK15 induced autophagy. (A) HeLa cells were transfected with control vector or HA-MAPK15. Two hours (h) before 
harvesting, cells were starved (Starv) or treated with rapamycin (Rap, 200 nM), where indicated. Lysates were analyzed by WB, with indicated antibod-
ies. LC3B was detected with anti-LC3B antibody (Nanotools). The LC3B-II and MAPK1 amounts were quanti!ed by NIH ImageJ software. (B) HeLa cells 
were transfected with control vector or HA-MAPK15. One hour before harvesting, cells were treated with E64d (10 μg/ml), where indicated. Lysates 
were analyzed by WB, with indicated antibodies. LC3B was detected with anti-LC3B antibody (Nanotools). The LC3B-II and MAPK1 amounts were 
quanti!ed by NIH ImageJ software. (C) HeLa T-Rex MAPK15 cells were treated with doxycycline (Doxy, 1 μM) for di#erent periods. Two hrs before 
harvesting, cells were starved, where indicated. Lysates were analyzed by WB, with indicated antibodies. LC3B was detected with anti-LC3B antibody 
(Nanotools). The LC3B-II and MAPK1 amounts were quanti!ed by NIH ImageJ software. (D) HeLa T-Rex MAPK15 cells were treated with Doxy for 16 h, 
where indicated. Cells were !xed and then permeabilized with 100 μg/ml digitonin. Cells were stained with anti-LC3B antibody (MBL) and revealed 
with AlexaFluor488-conjugated antibody. Nuclei were stained with DAPI. Lower panel of each !gure indicates the amount of LC3B dots per cell quanti-
!ed by Volocity software. Measures were obtained by analyzing at least 400 cells/sample from !ve di#erent experiments (n = 5). Measures were sub-
jected to one-way ANOVA test. Asterisks were attributed for the following signi!cance value: **p < 0.01. (E) Same as in (D), but, 4 h before !xing, cells 
were treated with Ba!lomycin A1 (Baf, 100 nM). (F) HeLa cells were transfected with control vector or HA-MAPK15. Before harvesting, cells were starved 
(Starv) for the indicated periods. Lysates were analyzed by WB, with indicated antibodies. (G) HeLa cells were transfected with nonsilencing siRNA or 
with MAPK15-speci!c siRNA. After 72 h, cells were !xed and permeabilized with 100 μg/ml digitonin. Cells were stained with anti-LC3B (MBL) antibody 
and revealed with AlexaFluor488-conjugated secondary antibody. Nuclei were stained with DAPI. Lower panel of each !gure indicate the amount of 
LC3B dots per cell quanti!ed by Volocity software. Measures were obtained by analyzing at least 400 cells/sample from three di#erent experiments  
(n = 3). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the following signi!cance value: ***p < 0.001. (H) Same as in 
(G), but, cells were starved for 1 h before !xing.
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of endogenous SQSTM1 protein upon MAPK15 expression 
in HeLa cells. As shown in Figure 4A, transiently transfected 
MAPK15 clearly induced SQSTM1 degradation. Similarly, 
increasing MAPK15 expression in our HeLa inducible cell line 
also stimulated SQSTM1 degradation at levels comparable to 
rapamycin and starvation, our positive controls (Fig. 4B).
In HeLa cells, SQSTM1 shows a cytoplasmic distribution 
in basal conditions while, although degraded at increased rate, 
it is relocalized to autophagic vesicles upon activation of auto-
phagy.46,47 Indeed, in our inducible HeLa expression system, 
MAPK15 clearly led to an increase in the number of SQSTM1 
positive puncta, similarly to what happens upon starvation, our 
positive control (Fig. 4C). These results therefore indicate that 
MAPK15 induces both SQSTM1 autophagic relocalization and 
its autophagic removal.
Recent data have demonstrated that LC3B phosphorylation 
negatively regulates autophagy.48 We therefore sought to establish 
whether MAPK15 also was able to impinge on LC3B phosphory-
lation to control this process. Indeed, MAPK15, while increasing 
LC3B-II levels, clearly reduced in vivo LC3B phosphorylation 
both in HeLa (Fig. 4D) and in 293T cells (Fig. S13). This evi-
dence suggested a mechanism involving MAPK15 in the con-
trol of ATG8-like proteins functions through additional proteins 
(possibly kinases and/or phosphatases).
MAPK15 directly bound mammalian ATG8-like proteins 
through a specific LIR-containing region in its C-terminal 
domain. Domains responsible for interaction of MAPK15 with 
SRC, TGFB1I1, ESRRA and PCNA have already been mapped 
to its C-terminal region.18,25-27 Here, we sought to identify the 
MAPK15 C-terminal region allowing interaction with ATG8-like 
proteins. To this purpose, different MAPK15 deletion mutants 
were examined (Fig. 5A), showing that all mutants containing 
the region 1–373 efficiently interacted with ATG8-like proteins 
whereas further deletion up to aa 300 strongly diminished co-
precipitation (Fig. 5B). Together with two-hybrid screening 
results, these data suggested that the region of MAPK15 neces-
sary for interaction with LC3B, GABARAP and GABARAPL1 
mapped between aa 300 and aa 373. Moreover, the MAPK15 
deletion mutant that did not interact with ATG8-like proteins 
(MAPK15 1–300) was also functionally impaired, being unable 
to localize to autophagic structures (Fig. 5C) and to induce the 
formation of autophagosomal vesicles (Fig. 5D).
Upon C-terminal lipidation, mammalian ATG8-like proteins 
are incorporated into the autophagosomal membrane where 
they promote the recruitment of a large cohort of proteins, with 
to autophagic vesicles.8,29,37,45 Indeed, in line with results obtained 
with LC3B, expression of MAPK15 in HeLa cells also led to 
an increase in the amount of GABARAP-II (Fig. S8A) and 
to a ~5-fold increase in the number of autophagic structures 
(Fig. S8B), as compared with uninduced cells, further confirm-
ing the ability of MAPK15 to stimulate autophagy.
Zacharogianni et al. recently reported that MAPK15 is sta-
bilized by starvation and mediates its effects on cellular secre-
tion.44 In line with these results, we observed that starvation was 
also able to induce MAPK15 activity (Fig. 3F), with a mecha-
nism possibly involving autophosphorylation,19,39 thereby clearly 
establishing starvation as a MAPK15-activating stimulus. Still, 
starvation did not influence the interaction between MAPK15 
and LC3B-II (Fig. S9), while it increased localization of this 
kinase to autophagic structures (Fig. S10), suggesting that this 
MAP kinase may take advantage of its “constitutive” interaction 
with ATG8 family members to be recruited to autophagosomal 
membranes, upon autophagic stimuli. Conversely, rapamycin, a 
pharmacological stimulus of autophagy acting on the MTOR 
kinase,35 did not induce MAPK15 activity (Fig. S11), suggesting 
that MAPK15 may utilize an MTOR-independent mechanism 
to induce autophagy, a conclusion also supported by the observa-
tion that starvation regulates secretion through MAPK15 in an 
MTOR-independent manner.44
Based on these data, we investigated the role of the endog-
enous MAPK15 protein in controlling not only basal but also 
starvation-induced cellular autophagy. To this purpose, MAPK15 
expression was silenced using a validated, specific siRNA 
(Fig. S12; refs. 21 and 25). By using this tool, we observed ~43% 
and ~67% reduction in the number of basal (full medium, FM) 
(Fig. 3G) and starvation-induced (Fig. 3H) autophagic struc-
tures, respectively, as compared with the corresponding cells 
transfected with scrambled siRNAs. Altogether, these data sup-
port a role for endogenous MAPK15 in controlling the rate of 
basal cellular autophagy that may be related to its ability to 
autophosphorylate and, therefore, maintain a constitutive level 
of activity in the cells even in the absence of upstream stimuli. 
Still, specific stimuli such as starvation may increase the activity 
of MAPK15 by possibly enhancing its stability44 and the phos-
phorylation of its TEY activation domain (please, see above), 
consequently increasing the rate of cellular autophagy.
MAPK15 induced SQSTM1 degradation and reduced 
LC3B inhibitory phosphorylation. Autophagic flux can be mea-
sured by determining the declining abundance of autophagic 
substrates such as SQSTM1.41,46 Hence, we tested the amount 
Figure 4 (See opposite page). MAPK15 induced SQSTM1 degradation and reduced LC3B inhibitory phosphorylation. (A) HeLa cells were transfected 
with control vector or HA-MAPK15. Four hrs before harvesting, cells were treated with Rap or CQ, where indicated. Lysates were analyzed by WB, with 
indicated antibodies. The SQSTM1 and MAPK1 amounts were quanti!ed by NIH ImageJ software. (B) HeLa T-Rex MAPK15 cells were treated with Doxy 
for 24 and 32 h, where indicated. Four hrs before harvesting, cells were starved or treated with Rap, where indicated. Lysates were analyzed by WB, 
with indicated antibodies. The SQSTM1 and MAPK1 amounts were quanti!ed by NIH ImageJ software. (C) HeLa T-Rex MAPK15 cells were treated with 
Doxy for 16 h or starved as indicated. Cells were !xed and then permeabilized with 100 μg/ml digitonin. Cells were stained with anti-SQSTM1 and anti-
MAPK15 antibodies and revealed with AlexaFluor488-conjugated and AlexaFluor555-conjugated secondary antibodies, respectively. Right panels, 
indicate the amount of SQSTM1 dots per cell quanti!ed by Volocity software. Measures were obtained by analyzing at least 400 cells/sample from four 
di#erent experiments (n = 4). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the following signi!cance value: ***p 
< 0.001. (D) HeLa cells were transfected with control vector or HA-MAPK15. One hour before harvesting, cells were treated with Rap, where indicated. 
Lysates were analyzed by WB, with indicated antibodies. Total LC3B was detected with anti-LC3B antibody (Sigma Aldrich). The phospho-LC3B, LC3B-I 
and MAPK1 amounts were quanti!ed by NIH ImageJ software.
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on autophagy induced by the activated kinase and by starva-
tion. Despite the lack of inhibitors of MAPK15 useful for clini-
cal applications, the Ro-318220 compound has already shown 
the ability to inhibit this MAP kinase,19,28 as also confirmed in 
our experimental settings (Fig. S16). In order to demonstrate 
that, in our MAPK15 inducible system, stimulation of auto-
phagy was dependent on MAPK15 kinase activity, we therefore 
treated doxycycline-stimulated cells with the Ro-318220 inhibi-
tor and observed a ~61% reduction in the number of punctate 
intracellular vacuoles stained for LC3B (Fig. 7E). In this con-
text, it is important to point out that Ro-318220 is also reported 
as a PKC inhibitor.54 Still, we feel confident that the inhibi-
tory effect that we observe by using this drug was not attrib-
utable to PKC, because, as this kinase inhibits autophagy,55,56 
its inhibition should have induced this process. Ultimately, to 
establish also a role for endogenous MAPK15 kinase activity in 
controlling starvation-dependent induction of autophagy, we 
also treated HeLa cells with the MAPK15 inhibitor, observ-
ing a ~79% reduction in the number of autophagic structures 
(Fig. 7F), mirroring results observed with MAPK15 siRNA 
(Fig. 3G and H). Additionally, the immunofluorescence data 
about the inhibition of autophagy by Ro-318220 were also 
confirmed by scoring anti-LC3B-II by western blot analysis 
(Fig. 7G and H). Altogether, these data supported a role for 
MAPK15 kinase activity in the control of autophagy.
Discussion
MAPK15 functions are far from being completely understood. 
The results described here showed that, in basal conditions as 
well as upon starvation, MAPK15 activity was able to control the 
rate of the autophagic process by interacting with mammalian 
ATG8 family proteins (Fig. 8). Based on the kinase activity of 
MAPK15 and on our results using the kinase-dead mutant and 
the Ro-318220 inhibitor, phosphorylation of proteins involved 
in the regulation of autophagy may be the mechanism by which 
MAPK15 affected this cellular process. However, ATG8 family 
members do not present conserved minimal MAP kinase phos-
phorylation motifs (Ser/Thr-Pro) and, therefore, they may not 
be direct targets of MAPK15 kinase activity. Indeed, recombi-
nant ATG8-like proteins performed very poorly as substrates 
for MAPK15 in in vitro kinase assays (Fig. S17). Conversely, 
the interaction between ATG8-like proteins and MAPK15 may 
be required for the correct localization of the MAP kinase, in 
order to gain full access to pools of specific substrates, such as 
other kinases and/or phosphatases, directly impinging on the 
autophagic process. Ultimately, we demonstrated that MAPK15 
indirectly affected LC3B inhibitory phosphorylation in vivo, 
suggesting that MAPK15 may be involved in complex pathways 
that integrate different stimuli in a coordinated cellular response. 
Additional work will be required to address these issues and to 
specifically dissect all the molecular steps involved in MAPK15-
dependent regulation of autophagy.
Further supporting and expanding our results, MAPK15 
has been recently shown to negatively regulate protein secre-
tion.44 More specifically, amino acid starvation, a strong inducer 
extensive binding partner overlap between family members, and 
frequent involvement of a conserved surface on ATG8-like pro-
teins known to interact with LC3-interacting regions (LIRs) 
usually represented by a conserved hydrophobic W/Y/F-X-X-
L/I/V motif.10,49,50 Indeed, specific mutations in the LIR often 
reduce the binding of LIR-containing proteins to ATG8 fam-
ily members.51-53 Based on the relative low sequence complex-
ity of the LIR consensus, we identified seven potential LIR 
motifs in full length MAPK15 (Fig S14A). Among them, the 
most conserved across MAPK15 orthologous genes (Fig. 6A) 
was localized within the MAPK15 300–373 region (Fig. S14B). 
We decided to focus on this LIR, based on the already demon-
strated importance of this fragment for the interaction between 
MAPK15 and ATG8-like proteins. To definitively prove a direct 
mode of interaction, we performed in vitro affinity precipitation 
among bacterially purified, His-tagged, LC3B and GABARAP 
proteins and the GST-tagged 300–373 fragment of MAPK15 
(GST-MAPK15_300–373), both in its wild-type (WT) and 
in its mutated form in the key tyrosine (aa 340) and isoleucine 
(aa 343) residues of the LIR10,50 (GST-MAPK15_300–373_
AXXA). As shown in Figure 6B, both ATG8-like proteins spe-
cifically interacted with the purified aa 300–373 of MAPK15 
but such interactions were significantly impaired by mutating 
the conserved LIR motif. Finally, by in vivo affinity-precipitation 
experiments between the LIR-mutated MAPK15 and LC3B, we 
confirmed that this specific domain strongly affected the abil-
ity of MAPK15 to be recruited by this protein (Fig. 6C). Also 
in this case, we functionally validated these data in HeLa cells, 
as expression of the MAPK15 protein mutated in the putative 
LIR motif (HA-MAPK15_AXXA) was unable to localize to 
autophagic vesicles (Fig. 6D), to induce the formation of lipi-
dated LC3B, to stimulate the disposal of SQSTM1 protein (Fig. 
6E) and to induce an increase in the number of autophagosomes 
(Fig. 6F). Altogether, these data further expanded our demon-
stration of the interaction among these proteins by establishing a 
direct interaction mechanism mediated by a classical LIR motif 
contained in the MAPK15 300–373 region, supporting the rel-
evance of this region in the MAPK15-dependent mechanisms 
controlling autophagy.
The catalytic activity of MAPK15 was required for its abil-
ity to control autophagy. We next speculated that MAPK15 
kinase activity might be involved in the control of autophagy. 
Therefore, we first used a kinase-dead MAPK15 mutant 
(MAPK15_KD)19 and established that it was unable to induce an 
increase of LC3B-II (Fig. 7A), suggesting that MAPK15 kinase 
activity was necessary for this protein to induce autophagy. These 
data were further confirmed by immunofluorescence micros-
copy, as MAPK15_KD was also unable to induce the forma-
tion of autophagosomal structures (Fig. 7B). This effect was not 
dependent on an impairment of MAPK15 binding to ATG8-like 
proteins, as MAPK15_KD was able to bind to LC3B (Fig. 7C) 
and to colocalize with this protein to autophagosomal structures 
(Fig. 7D; Fig. S15) to an extent comparable to wild-type 
MAPK15.
To confirm these data with a different approach, we also set 
up to investigate the effect of MAPK15 chemical inhibition 
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overcome this particularly stressful situation. As such, our data 
suggested a novel mechanism to understand the role of MAPK15 
in cellular physiology and human pathology.
In this work, we also provided several insights into the molecu-
lar mechanism of MAPK15-dependent stimulation of autophagy. 
Specifically, our data underlined the importance of the interac-
tion of MAPK15 with mammalian ATG8-like proteins, through 
a specific LIR in the kinase C-terminal domain (Fig. 6). Also, 
of autophagy, has been demonstrated to cause stabilization of 
MAPK15 protein and thus to inhibit protein secretion, in an 
MTOR-independent manner. In this context, our observation 
that starvation, but not the specific MTOR inhibitor rapamycin,35 
stimulated MAPK15 is really intriguing. MAPK15 may therefore 
coordinate cellular responses to starvation by both turning off 
the protein secretion pathway and upregulating the autophagic 
machinery, in order to give the cell more chances to successfully 
Figure 5. MAPK15 bound ATG8-like protein through region 300–373 aa. (A) Scheme depicts MAPK15 full length and its deletion mutants. (B) Bacteri-
ally expressed GST-GABARAP (lanes 3–7), GST-GABARAPL1 (lanes 8–12), GST-LC3B (lanes 13–17) or GST alone (lanes 1–2) immobilized on glutathione-
Sepharose Beads 4B, were incubated with lysates of 293T cells transiently transfected with a control vector or with full length HA-MAPK15_WT or with 
HA-MAPK15 deletion mutants, subjected to a"nity precipitation and then analyzed by WB. (C) Colocalization rate of LC3 with MAPK15 or its deletion 
mutants in HeLa transfected cells was obtained by analyzing at least 400 cells/sample from three di#erent experiments (n = 3). Measures were sub-
jected to one-way ANOVA test. Asterisks were attributed for the following signi!cance value: ***p < 0.001. (D) The graph indicates the amount of LC3B 
dots per cell in HeLa cells transfected with MAPK15 or its deletion mutants, quanti!ed by Volocity software. Measures were obtained by analyzing at 
least 400 cells/sample from three di#erent experiments (n = 3). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the 
following signi!cance value: **p < 0.01.
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Figure 6. MAPK15 bound ATG8-like protein through a speci!c LIR-containing region. (A) Alignment of a portion of MAPK15 protein sequence across 
the species showing the position of the conserved LIR motif. (B) GST, GST-MAPK15_300–373_WT or GST-MAPK15_300–373_AXXA were incubated for 
1 h at 4°C with 6xHis-GABARAP or 6xHis-LC3B. Proteins were then a"nity-puri!ed by glutathione-Sepharose Beads 4B, extensively washed and loaded 
on SDS-PAGE gels. Total proteins were stained with Coomassie stain. The total and MAPK15-bound amounts of 6xHis-tagged ATG8-like protein were 
quanti!ed by NIH ImageJ software. (C) HeLa cells were cotransfected with a control vector or with GFP-LC3B, MAPK15_WT-V5–6xHis or MAPK15_AXXA-
V5–6xHis. Lysates (1 mg) were incubated with NiNTA-Sepharose Beads 4B, subjected to in vivo a"nity precipitation, and then analyzed by WB. The 
total and MAPK15-bound amounts of GFP-tagged ATG8-like protein were quanti!ed by NIH ImageJ software. (D) Colocalization rate of LC3 with 
MAPK15_WT or MAPK15_AXXA in HeLa transfected cells was obtained by analyzing at least 400 cells/sample from three di#erent experiments (n = 3). 
Measures were subjected to one-way ANOVA test. Asterisks were attributed for the following signi!cance value: ***p < 0.001. (E) HeLa cells were trans-
fected with control vector or HA-MAPK15 (WT) or its mutants. Lysates were analyzed by WB, with indicated antibodies. LC3B was detected with anti-
LC3B antibody (Nanotools). The LC3B-II, SQSTM1 and MAPK1 amounts were quanti!ed by NIH ImageJ software. (F) The graph indicates the amount of 
LC3B dots per cell in HeLa cells transfected with MAPK15_WT or MAPK15_AXXA, quanti!ed by Volocity software. Measures were obtained by analyzing 
at least 400 cells/sample from three di#erent experiments (n = 3). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the 
following signi!cance value: **p < 0.01.
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specific human oncogenes,68,69 thus supporting cancer cell sur-
vival by eliminating specific apoptosis-inducing proteins.70,71 
Consequently, inhibition of autophagy is currently considered 
a promising approach to sensitize cancer cells to different thera-
pies.72 Based on the already demonstrated ability of different 
human oncogenes to activate MAPK15,20 we can hypothesize 
that this kinase, by controlling autophagy, may participate in 
the tumorigenic process sustained by these oncogenes. This, 
therefore, allows us to speculate that MAPK15 inhibition may 
be beneficial for the treatment of these tumors. In this scenario, 
the precise nature of the stimuli controlling MAPK15 expres-
sion and activity and of the mechanisms triggered by MAPK15 
to regulate autophagy in physiological as well as in pathological 
conditions warrant further investigation.
Materials and Methods
Reagents and antibodies. Bafilomycin A1 (Santa Cruz 
Biotechnology, sc-201550) and Ro-318220 (VWR International, 
557521-500) were dissolved in DMSO. Chloroquine (C6628), 
rapamycin (R0395), doxycycline (D9891) were purchased from 
Sigma Aldrich. Hank’s medium (H15-010), used as starvation 
medium, was obtained by PAA. The following primary antibod-
ies were used for western blots, co-immunoprecipitations, and 
confocal microscopy experiments: anti-MAPK15/ERK8 (custom 
preparation), anti-HA (Covance, MMS-101R) and anti-GFP 
(Covance, MMS-118P), anti-LC3B (Nanotools, 0231-1000), 
anti-LC3B (MBL, M152-3) and anti-GABARAP (MBL, M135-
3), anti-LC3B (Sigma Aldrich, L7543), anti-ATG5 (Sigma 
Aldrich, A0731) and anti-ATG7 (Sigma Aldrich, A2856), anti-
phospho-TEY (Cell Signalling, 9101), anti-SQSTM1/p62 (BD 
Biosciences, 610833), anti-phospho-LC3 (Abgent, AP3301a), 
anti-MAPK1/ERK2 (Santa Cruz Biotechnology, sc-154), anti-
LAMP1 (Santa Cruz Biotechnology, sc-20011), anti-NFK-
BIA/IκBα (Santa Cruz Biotechnology, sc-371), anti-Calnexin 
(Santa Cruz Biotechnology, sc-23954) and anti-JUN (Santa 
Cruz Biotechnology, sc-45). The following secondary antibod-
ies were used for western blot experiments: anti-mouse (Santa 
Cruz Biotechnology, sc-2004) and anti-rabbit (Santa Cruz 
Biotechnology, sc-2005) HRP-conjugated IgGs.
Expression vectors. All the vectors used in yeast two-hybrid 
screening were previously described.25 pCEFL-HA-MAPK15, 
and all its deletion mutants were already described20 except for 
1–300 MAPK15 deletion mutant which was generated by cloning 
the cDNA, obtained by PCR amplification, in the pCEFL-HA 
vector. pcDNA4-Tet-On-MAPK15 was generated by subcloning 
the MAPK15 cDNA, obtained by restriction enzyme digestion 
from pCEFL-HA-MAPK15, into the pcDNA4 Tet-inducible 
vector, kindly provided from Francesca Carlomagno (Università 
degli Studi di Napoli). pcDNA-Tet-on-LacZ was also kindly pro-
vided from F. Carlomagno. A double point mutation of MAPK15 
in Y340A and I343A was obtained by QuikChange site-directed 
mutagenesis kit (Stratagene, 200518) from pCEFL-HA-MAPK15 
and generated pCEFL-HA-MAPK15_AXXA. For interaction 
analysis, MAPK15_WT and MAPK15_AXXA were also sub-
cloned by restriction enzyme digestion on pEF1_V5–6xHis 
they suggested the existence of unknown MAPK15 substrates 
involved in autophagy, as MAPK15 kinase activity was strictly 
required to induce autophagy (Fig. 7). In this context, it is worth 
noting the dual relevance of the 300–373 MAPK15 region for 
the regulation of autophagy, as it both controlled the binding 
of the kinase to ATG8-like proteins through the conserved LIR 
(Fig. 5B) and was required for kinase activity (Fig. S18; ref. 20).
Recent reports have suggested a role for MAPK15 in the 
response to DNA damage and, possibly, in the maintenance of 
genomic stability.21,27,28 Interestingly, as previously described, 
both MAPK15 silencing27 and misregulation of the autophagic 
process57 are associated with increased DNA damage, gene ampli-
fication and aneuploidy, implying a key role for autophagy in 
limiting chromosomal instability. Our data therefore suggested 
that induction of autophagy through this MAP kinase may par-
ticipate, together with PCNA stabilization27 and induction of 
telomerase activity,28 to a general MAPK15-dependent program 
aiming at maintaining genomic integrity.
Mitochondria are the intracellular compartment where oxi-
dative phosphorylation takes place, using glucose and oxygen to 
produce the ATP required for cell functions.58 This process leads 
to the formation of reactive oxygen species (ROS), that leak from 
both normal and, especially, damaged mitochondria, resulting in 
oxidative damage to proteins, lipids and nucleic acids.59 Autophagy 
plays a key role in the degradation of damaged mitochondria 
and, indeed, autophagy-deficient cells exhibit an increase in ROS 
production.60 Importantly, hydrogen peroxide, a source of ROS, 
activated MAPK15 (Fig. S11; ref. 21). Consequently, our results 
suggested that MAPK15 may be activated as a consequence of 
ROS generation to stimulate autophagy, accelerating degrada-
tion of damaged mitochondria. Supporting this hypothesis, we 
recently have demonstrated that MAPK15 also controls the tran-
scriptional activity of ESRRA,25 a key regulator of mitochondrial 
biogenesis and functions.61 In this context, MAPK15 may be 
involved in a novel molecular mechanism aimed to mitigate oxi-
dative stress and consequent DNA damage in response to ROS 
as well as to other stimuli. These and additional hypotheses are 
currently under investigation.
Autophagy has been recently regarded as an attractive tar-
get for successful cancer therapy. However, huge efforts are 
still needed to address its specific role in cell transformation, 
mostly concerning its apparently contradictory functions as a 
proapoptotic or prosurvival mechanism. Indeed, autophagy 
plays a critical protective role in the maintenance of energy 
homeostasis and protein and organelle quality control,62 thus 
protecting cells from damage accumulation under conditions 
of metabolic stress. Moreover, reduced levels or absence of pro-
teins required for autophagy have been associated to facilitated 
tumor establishment in mouse models and human tumors.63-65 
Based on this evidence, autophagy has been addressed as a 
tumor suppressor mechanism. Conversely, cells defective for 
autophagy are more sensitive to metabolic- or chemotherapy-
induced stress,14,66 suggesting that autophagy might represent 
an antiapoptotic mechanism which contributes to resistance to 
a vast array of antineoplastic drugs.67 Nonetheless, autophagy 
may also be activated in tumor cells in response to stress and 
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For immunofluorescence experiments and western blot analy-
sis, 5 × 104 cells were seeded in 12-well plates (2 × 105 for 6-well 
plates) and transfected with 200 ng (500 ng in 6-well plates) of 
each expression vector, using Lipofectamine LTX (Invitrogen, 
15338500). All experiments were performed, unless specified, 
24 h after transfection. For confocal microscopy experiments, 
2.5 × 104 cells were seeded on coverslips placed onto 12-well 
plates. Each sample was transfected with 200 ng of each plasmid 
using Lipofectamine LTX.
RNA interference. MAPK15-specific siRNA (target sequence 
5'-TTG CTT GGA GGC TAC TCC CAA-3') and nonsilenc-
ing siRNA (scrambled, SCR; target sequence 5'-AAT TCT CCG 
AAC GTG TCA CGT-3') were obtained from Qiagen. The 
ATG5-specific siRNA pool (62012000062) was purchased from 
Riboxx. HeLa cells were transfected with siRNA at a final con-
centration of 5 nM using HiPerFect (Qiagen, 301707), accord-
ing to the manufacturer’s instructions. Samples were analyzed, 
unless specified, 72 h after transfection.
Western blots. For LC3B analysis,73 total lysates were obtained 
by resuspending washed cellular pellets in 1× Laemmli buffer 
and incubating for 10 min at 95°C, in continuous agitation. For 
SQSTM1 analysis,74 total lysates were obtained by resuspending 
cellular pellets in RIPA buffer (50 mM TRIS-HCl pH 8.0, 150 
mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1% NP-40). 
For western blot analysis, proteins derived from total lysates, 
immunoprecipitations or affinity precipitations were loaded on 
polyacrylamide gels and resolved by SDS-PAGE, transferred 
to Immobilon-P PVDF membrane (Millipore, IPVH00010), 
probed with appropriate antibodies and revealed by enhanced 
chemoluminescence detection (ECL Plus; GE Healthcare, 
RPN2132). For detection of endogenous MAPK15 protein an 
amount of 200 μg of total protein extract was loaded for each 
sample. Densitometric analysis of western blots was performed 
with NIH Image J 1.43u (National Institutes of Health).
Yeast two-hybrid. Yeast two-hybrid screening was performed 
as previously described.25 Thanks to the presence of a myc epitope 
in the resulting fusion protein (myc-GAL4-MAPK15 C-term), 
we also confirmed the expression of such protein in yeast. We 
expression vector (Invitrogen, V920-20), generating pEF1_
MAPK15_WT-V5-6xHis and pEF1_MAPK15_AXXA-V5-
6xHis. MAPK15 300–373 aa (corresponding to 900–1119 bp) 
cDNA was subcloned by PCR into pGEX4T3 plasmid from 
pCEFL-HA-MAPK15 and pCEFL-HA-MAPK15_AXXA, gen-
erating pGEX4T3-MAPK15_300–373_WT and pGEX4T3-
MAPK15_300–373_AXXA. MAPK15 kinase dead mutant 
D155A (MAPK15 KD) cDNA was a generous gift from Philip 
Cohen (University of Dundee) and then subcloned into pCEFL-
HA plasmid. pCEFL-EGFP-GABARAP, pGEX4T3-GABARAP 
and pRSET-GABARAP were generated by subcloning in these 
vectors the GABARAP cDNA obtained by PCR from a pCMVS-
port6-GABARAP template (Invitrogen, Clone ID 5528016). 
pCEFL-GFP-GABARAPL1, pGEX4T3-GABARAPL1 were 
generated by subcloning in these vectors the GABARAPL1 
cDNA, obtained by PCR from pCMVSport6-GABARAPL1 
template (Invitrogen, Clone ID 6185293). pCEFL-EGFP-LC3B, 
pGEX4T3-LC3B and pRSET-LC3B were generated by subclon-
ing in these vectors the LC3B cDNA (OpenBiosystem, Clone ID 
5276841). pGIPZ plasmids encoding for scrambled shRNA and 
ATG7 shRNA were kindly provided from Fabrizio Condorelli 
(Università del Piemonte Orientale).
Cell culture and transfections. 293T and HeLa cells were 
maintained in Dulbecco’s modified Eagle medium (DMEM; 
PAA, E15-009) supplemented with 10% fetal bovine serum 
(PAA, A15-151), 2 mM L-glutamine and 100 units/ml penicil-
lin-streptomycin at 37°C in an atmosphere of 5% CO2/air. HeLa 
HA-MAPK15_WT and HeLa HA-MAPK15_KD were gener-
ated by transfecting HeLa cells with pCEFL-HA-MAPK15_WT 
and pCEFL-HA-MAPK15_KD respectively; stably expressing 
cells were then plated at limiting diluition in 96-well plates to 
obtain single cell clones. HeLa T-Rex cells and HeLa T-Rex β-Gal 
cells, were maintained in DMEM supplemented with 10% fetal 
bovine serum (Clonetech, 631106), 2 mM L-glutamine, 5 ug/ml 
blasticidin and 100 units/ml penicillin-streptomycin at 37°C in 
an atmosphere of 5% CO2/air. Doxycycline-inducible cell lines 
for MAPK15 were generated by transfecting HeLa T-Rex cells 
with pcDNA4-Tet-On-MAPK15 plasmid.
Figure 7 (See opposite page). The catalytic activity of MAPK15 was required for its ability to control autophagy. (A) HeLa cells were transfected with 
control vector or HA-MAPK15_WT or HA-MAPK15_KD. Lysates were analyzed by WB, with indicated antibodies. LC3B was detected with anti-LC3B  
antibody (Nanotools). Right panel, steady-state autophagy. Left panel, autophagic $ux. (B) The graph indicates the amount of LC3B dots per cell in 
HeLa cells transfected with MAPK15_WT or MAPK15_KD, quanti!ed by Volocity software. Measures were obtained by analyzing at least 400 cells/sam-
ple from three di#erent experiments (n = 3). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the following signi!cance 
value: **p < 0.01. (C) For a"nity precipitation (AP), bacterially expressed GST-LC3B or GST alone, immobilized on glutathione-Sepharose Beads 4B were 
incubated with lysates of 293T cells transiently transfected with a control vector or with HA-MAPK15_WT or HA-MAPK15_KD, then analyzed by western 
blot. (D) Colocalization rate of LC3 and MAPK15 in HeLa cells stably expressing MAPK15_WT or MAPK15_KD was obtained by analyzing at least 400 
cells/sample from three di#erent experiments (n = 3). (E) HeLa T-Rex MAPK15 cells were treated with Doxy for 2 h, then Ro-318220 (1 μM) was added 
to culture medium for the following 6 h, where indicated. Cells were !xed and then permeabilized with 100 μg/ml digitonin. Cells were stained with 
anti-LC3B (MBL) antibody and revealed with AlexaFluor488-conjugated antibody. Nuclei were stained with DAPI. The LC3B-positive dots per cell were 
quanti!ed using Volocity software (right panel). Measures were obtained by analyzing at least 400 cells/sample from three di#erent experiments (n = 
3). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the following signi!cance values: *p < 0.05, **p < 0.01. (F) HeLa cells 
were treated with Ro-318220 (1 μM) for 6 h and/or then starved for 1 h, where indicated. Cells were !xed and permeabilized with 100 μg/ml digitonin, 
then stained with anti-LC3B antibody (MBL) and revealed with AlexaFluor488-conjugated secondary antibody. Nuclei were stained with DAPI. The 
number of LC3B positive dots per cell was quanti!ed using the Volocity software (right panel). Measures were obtained by analyzing at least 400 cells/
sample from three di#erent experiments (n = 3). Measures were subjected to one-way ANOVA test. Asterisks were attributed for the following signi!-
cance values: *p < 0.05, **p < 0.01. At the concentration used, the Ro-318220 compound did not a#ect cell viability. (G) HeLa cells were treated as in (E). 
Lysates were analyzed by WB, with indicated antibodies. LC3B was detected with anti-LC3B antibody (Nanotools). (H) HeLa cells were treated as in (F). 
Lysates were analyzed by WB, with indicated antibodies. LC3B was detected with anti-LC3B antibody (Nanotools).
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2 h at 4°C. Protein complexes were then purified by 
glutathione conjugated beads. Protein complexes have 
been resuspended in Laemmli buffer and loaded on gels 
for SDS-PAGE and western blot analysis or Coomassie 
staining.
Ni-NTA affinity precipitation. Whole cell lysates 
were obtained by resuspending washed pellets in RIPA 
buffer with 20 mM Imidazole. Protein complexes were 
then purified by incubating with Ni-NTA-conjugated 
beads (Qiagen, 30210). Protein complexes were resus-
pended in Laemmli buffer and loaded on gels for SDS-
PAGE and western blot analysis.
GST-pulldown of purified proteins. 6xHis-tagged 
ATG8-like proteins and GST-MAPK15_300–373_WT 
or GST-MAPK15_300–373_AXXA were incubated 
in 25 mM TRIS-HCl pH 8.0, 300 mM NaCl, 0.5% 
Tween 20 for 1 h. Protein complexes were then purified 
by glutathione conjugated beads. After several washes, 
protein complexes were resuspended in Laemmli buf-
fer and loaded on gels for SDS-PAGE and western blot 
analysis.
Coomassie staining. Bacterially expressed pro-
teins were loaded on SDS-PAGE gels, stained with 
SimplyBlue SafeStain (Invitrogen, LC6060), and 
revealed using the Odyssey Infrared Imaging System 
(Li-Cor Biosciences, 9120).
Immunofluorescence (IF). Cells were washed with 
PBS, then fixed with 4% paraformaldehyde in PBS for 
20 min and permeabilized with 0.2% Triton X-100 
solution for 5 min or 100 μg/ml digitonin solution 
(Invitrogen, BN2006) for 20 min, as indicated. Cells were incu-
bated with appropriate primary antibodies for 1 h, washed three 
times with PBS, and then incubated with appropriate Alexa Fluor 
488-conjugated (Invitrogen, A21202), Alexa Fluor 555-con-
jugated (Invitrogen, A31272) or Alexa Fluor 647-conjugated 
(Invitrogen, A21245) secondary antibodies and then washed 
again three times in PBS. Nuclei were stained with a solution 
of 1.5 μM of 4',6-diamidino-2-phenylindole (DAPI; Sigma 
Aldrich, D9542) in PBS for 5 min. Coverslips were mounted 
in fluorescence mounting medium (Dako, S3023). Samples 
were visualized on a TSC SP5 confocal microscope (Leica, 
5100000750) installed on an inverted LEICA DMI 6000CS 
(10741320) microscope and equipped with an oil immersion 
PlanApo 63× 1.4 NA objective. Images were acquired using the 
LAS AF acquisition software (Leica, 10210).
Subcellular fractionation. Cytoplasmic, membrane and 
nuclear fractions were obtained by the Subcellular Protein 
Fractionation Kit (Thermo Scientific, 78840), according to 
the manufacturer’s instructions. Briefly, cells were harvested by 
trypsinization and centrifuged at 500 g for 5 min. Cells were 
then washed in PBS and resuspended in cytoplasm extraction 
buffer and centrifuged at 500 g for 5 min. Supernatants were 
collected as cytoplasm extracts and pellets further suspended in 
Membrane Extraction Buffer. Following 10 min incubation on 
ice, resuspended pellets were centrifuged at 3000 g for 5 min. 
Supernatants were then collected as membrane extracts and 
also confirmed that our bait was not able to activate, by itself, the 
transcription of reporter genes. In addition, we confirmed that 
our bait could not interact directly with the GAL4 transactiva-
tion domain contained in the plasmid employed to engineer the 
cDNA library used for the screening.
Bacterial expression of GST- and 6xHis-fusion proteins. The 
BL21(DE3)pLys strain of Escherichia coli was transformed with 
the pRSET-6xHis alone or encoding for GABARAP and LC3B 
respectively, and with the pGEX4T3 vector alone or encoding the 
GABARAP, GABARAPL1, LC3B, MAPK15_300–373_WT 
and MAPK15_300–373_AXXA fusion proteins respectively. 
Bacterially expressed 6xHis- and GST-fusion proteins were puri-
fied as previously described.75
Coimmunoprecipitations. Whole cell lysates were obtained 
by resuspending washed pellets in RIPA buffer. Lysates 
were pre-cleaned with Protein A/G conjugated beads (Santa 
Cruz Biotechnology, sc-2003), and then incubated with 
appropriate antibodies for 2 h at 4°C. Immunocomplexes were 
purified by incubating lysates with Protein A/G-conjugated 
beads. Immunocomplexes were next resuspended in Laemmli 
buffer and loaded on gels for SDS-PAGE and western blot 
analysis.
GST affinity precipitation. Whole cell lysates were obtained 
by resuspending washed pellets in RIPA buffer. Lysates were pre-
cleaned with glutathione conjugated beads (Amersham, 17-5132-
03) and then incubated with GST or GST-fusion proteins for 
Figure 8. MAPK15 in the control of the autophagic process. A fraction of the 
MAPK15 protein is localized to autophagic structures by binding to mammalian 
ATG8 proteins, through a conserved LIR. When localized to these compartments, 
in basal conditions as well as upon starvation, MAPK15 enzymatic activity is able 
to control the rate of autophagy by phosphorylating downstream substrates, pos-
sibly additional ATG proteins, ultimately mediating its e#ect on this process.
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pellets further suspended in nuclear extraction buffer. Following 
30 min incubation on ice, resuspended pellets were centrifuged 
at 5000 g for 5 min. Then, supernatants were collected as nuclear 
extracts. All subcellular fraction extracts were then analyzed by 
western blot.
Dot counts, colocalization rate and statistical analysis. 
For the LC3B-, GABARAP- and SQSTM1-positive dots count, 
we performed intensitometric analysis of fluorescence using 
the Quantitation Module of Volocity software (PerkinElmer 
Life Science, I40250). Colocalization rate was also measured 
by the Quantitation Module of Volocity software. Dot counts 
and colocalization rate were subjected to statistical analysis. 
Measures were obtained by analyzing at least 400 cells/sample 
from three different experiments. Significance (p value) was 
obtained by one-way ANOVA test. Asterisks were attributed for 
the following significance values: *p < 0.05, **p < 0.01, ***p < 
0.001.
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